NEW YORK (GenomeWeb News) — Belgian biopharmaceutical company UCB is using two of Genedata's software platforms to support its drug-development programs, Genedata said today.
Genedata said UCB has deployed the integrated Phylosopher and Expressionist software platforms. The drug maker will use the platforms to study CNS disorders, allergy and respiratory diseases, immune and inflammatory disorders, and oncology.
Expressionist, which is used in biomarker research, is a modular enterprise system that includes public and private data and sample information.
Phylosopher, meantime, integrates proprietary information with public data and links information such as genome sequences and transcriptomic, proteomic, and metabolomic data with functional information and annotations. It also links phenotypes relevant to disease.
Financial terms of the agreement were not released.